Project members

We are committed to providing innovative treatments to patients through iPS cell technology.

At T-CiRA, several novel research projects focusing on the creation of medical applications of iPSC are underway, led by nine principal investigators (PI) with Co-principal investigators (Co-PI) from Takeda.


 

Cell Therapy

Group 353.png

Development of a novel immunotherapy using iPSC-derived immune cells

Shin Kaneko(PI, CiRA)
Akira Hayashi(Co-PI, Takeda)
Yoshiaki Kassai(Co-PI, Takeda)
Shoichi Iriguchi(Sub PI, CiRA)
Keiko Koga(Sub PI, Takeda)

Group 355.png

Research on Cell Therapy against Type 1 Diabetes

Taro Toyoda (PI, CiRA)
Ryo Ito(Co-PI, Takeda)
Shuhei Konagaya(Sub PI, CiRA)
Yutaka Tanoue(Sub PI, Takeda)
Hikaru Ueno(Sub PI, Takeda)
Noriko Yamazoe(SubPI, Takeda)

Group 357.png

Development of an iPSC-derived cardiomyocyte cell therapy for severe heart failure

Yoshinori Yoshida (PI, CiRA)
Tomoyuki Nishimoto (Co-PI, Takeda)
Norihisa Tamura(Sub PI, Takeda)
Yasuharu Kamachi(Sub PI, Takeda)





創薬

Group 359.png

ALS/ASD drug discovery and development using patient derived iPSCs

Haruhisa Inoue (PI, CiRA)
Hiroshi Yukitake (Co-PI, Takeda)
Inigo Narvaiza(Sub PI, Takeda)
Keisuke Shibata(Sub PI, Takeda)

Group 361.png

Drug discovery for intractable muscular disease using patient-derived iPSCs

Hidetoshi Sakurai (PI, CiRA)
Ryuichi Tozawa (Co-PI, Takeda)
Tomoya Uchimura(Sub PI, CiRA)
Masahiro OKa(Sub PI, Takeda)
Tatsuo Oikawa(Sub PI, Takeda)



Group 363.png

Development of therapeutic agents for rare hereditary diseases using iPS cells

Tadashi Suzuki (PI, RIKEN)
Ryuichi Tozawa(Co-PI, Takeda)
Hiroto Hirayama(Sub PI, RIKEN)
Takayuki Kamei(Sub PI, Takeda)

Group 364.png

Drug discovery for genetic cardiac disease using a novel iPSC-based platform

Yoshinori Yoshida(PI, CiRA)
Tomoyuki Nishimoto(Co-PI, Takeda)
Kenichi Imahashi(Co-PI, Takeda)

 





Platform Technology

Group 366.png

A new research platform with human iPSC-derived neural crest cells and its applications for drug discovery and regenerative medicine

Makoto Ikeya (PI, CiRA)
Hirokazu Matsumoto (Co PI, Takeda)
Daisuke Kamiya (Sub PI, CiRA)
Yayoi Toyooka (Sub PI, CiRA)
Kazumi Take (Sub PI, Takeda)
Teruyoshi Yamashita (Sub PI, Takeda)

Group 370.png

Development of novel gene therapy for Duchenne muscular dystrophy, by using genome editing and delivery technologies

Akitsu Hotta (PI, CiRA)
Naoto Inukai (Co-PI, Takeda)
Eriya Kenjo(Sub PI, Takeda)
Hiroyuki Hozumi(Sub PI, Takeda)



プロジェクト詳細


button_pdf_E.png